Provided by Tiger Trade Technology Pte. Ltd.

Exelixis

54.64
+0.19000.35%
Pre-market: 54.700.0600+0.11%04:03 EDT
Volume:2.25M
Turnover:122.44M
Market Cap:13.54B
PE:17.18
High:55.02
Open:54.10
Low:53.43
Close:54.45
52wk High:57.57
52wk Low:33.76
Shares:247.78M
Float Shares:214.00M
Volume Ratio:1.22
T/O Rate:1.05%
Dividend:- -
Dividend Rate:- -
EPS(TTM):3.18
EPS(LYR):2.78
ROE:44.39%
ROA:23.97%
PB:7.34
PE(LYR):19.65

Loading ...

Exelixis Inc - Maintains 2026 Financial Guidance

THOMSON REUTERS
·
May 06

Exelixis Inc - in May, Board Authorizes $750 Mln Stock Repurchase Program in May 2026

THOMSON REUTERS
·
May 06

Exelixis Inc - Initiates Stellar-201 Phase 2 Trial of Zanzalintinib in Recurrent Meningioma

THOMSON REUTERS
·
May 06

Earning Preview: Exelixis Q1 revenue is expected to increase by 21.51%, and institutional views are cautious with Hold calls dominant

Earnings Agent
·
Apr 28

Exelixis and Merck Advance Key Phase 3 Kidney Cancer Trial, Setting Up a New Catalyst for EXEL

TIPRANKS
·
Apr 24

Does Exelixis (EXEL) Gain Quiet Competitive Leverage From a Rival’s Kidney Cancer Setback?

Simply Wall St.
·
Apr 23

The Tactical Trio Blueprint For Solid Balance Sheet And Fundamentals

Simply Wall St.
·
Apr 22

Exelixis schedules quarterly results release and conference call

Reuters
·
Apr 22

Exelixis Is Maintained at Equal-Weight by Barclays

Dow Jones
·
Apr 20

A Look At Exelixis (EXEL) Valuation As CABOMETYX Growth And Trial Outlook Shape Expectations

Simply Wall St.
·
Apr 17

Exelixis publishes 2025 annual report

Reuters
·
Apr 16

Exelixis announces annual shareholder meeting

Reuters
·
Apr 16

Wells Fargo Sticks to Its Hold Rating for Exelixis (EXEL)

TIPRANKS
·
Apr 14

Exelixis (EXEL) Gets a Hold from RBC Capital

TIPRANKS
·
Apr 09

Wells Fargo Sticks to Its Hold Rating for Exelixis (EXEL)

TIPRANKS
·
Apr 02

Genmab names Margarida Duarte general manager for Europe and emerging markets

Reuters
·
Apr 01

Jefferies Sticks to Its Buy Rating for Exelixis (EXEL)

TIPRANKS
·
Mar 25

Assessing Exelixis (EXEL) Valuation After Analysts Lift 2026 Earnings Forecasts

Simply Wall St.
·
Mar 13

Analysts Offer Insights on Healthcare Companies: Exelixis (EXEL), Hims & Hers Health (HIMS) and Regeneron (REGN)

TIPRANKS
·
Mar 09